408 filings
Page 2 of 21
8-K
rdoilrvbntlcu
23 Aug 22
Other Events
4:08pm
8-K
i9e8zs
22 Aug 22
Completion of Acquisition or Disposition of Assets
9:30am
8-K
x583u0v8n7 r4on
27 Jul 22
Innoviva Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
4:16pm
8-K
wz1r1276mci9tt
20 Jul 22
Entry into a Material Definitive Agreement
9:20am
8-K
kfw0up9j
13 Jul 22
Entry into a Material Definitive Agreement
5:27pm
8-K
8fi6rvf9u
11 Jul 22
Completion of Acquisition or Disposition of Assets
5:01pm
8-K
g0jb70 i8og
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
8-K
mjaum1j 87kw
23 May 22
Tender and Support Agreement
8:51pm
8-K/A
yt3xl4fd489jloo1qc
4 May 22
Departure of Directors or Certain Officers
3:29pm
8-K
hd9oxe 6dgl2hn
2 May 22
Departure of Directors or Certain Officers
5:27pm
8-K
fj7sesnplswc nwg
28 Apr 22
Submission of Matters to a Vote of Security Holders
6:25pm
8-K
wu1nq e96k2
27 Apr 22
Innoviva Reports First Quarter 2022 Financial Results
6:43pm
8-K
d8nzh
7 Apr 22
Regulation FD Disclosure
5:09pm
8-K
l6vgwuk2oqqy o4vw3
1 Apr 22
Entry into a Material Definitive Agreement
4:53pm
8-K
vnbitixczu71hipttuj
25 Mar 22
Changes in Registrant's Certifying Accountant
4:07pm
8-K
9lbqgg1
21 Mar 22
Entry into a Material Definitive Agreement
5:27pm
8-K
8ljcchtcp4di8z q85ay
8 Mar 22
Innoviva Announces Proposed Offering of $200 Million of Convertible Senior Notes
5:15pm
8-K
x8za1
9 Feb 22
Innoviva Reports Fourth Quarter 2021 Financial Results
4:55pm
8-K
msruebwc
13 Dec 21
Corporate Presentation December 2021
4:39pm
8-K
gaxpocpzt 3jxqv4w3
27 Oct 21
Innoviva Reports Third Quarter 2021 Financial Results
4:18pm